High Court considers requirements for an exclusive patent licence (Neurim v Mylan)

In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] EWHC 3270 (Pat). This case concerned the licensing of patented technology, specifically the use of licence terms relating to the control of proceedings. 

Click here to read more >

Full article available on PatentHub

Latest insights

More Insights
spring

How to better preserve use evidence for registered trademarks in China?

Sep 18 2024

Read More
data

Ofgem’s Consultation on the governance of the data sharing infrastructure (DSI)

Sep 17 2024

Read More

The DNA of Life Sciences Deals

Sep 17 2024

Read More